All In Biotech

Drug Trial Radar · NCT06244771

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

An Open-Label, Phase 1/2 Dose Escalation, Dose Expansion and Cohort Expansion Study Evaluating the Safety, PK and Clinical Activity of FMC-376 Monotherapy and in Combination With Pembrolizumab in Participants With KRAS G12C Mutated Advanced Solid Tumors

Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

293

Planned (sponsor's estimate)

Start

Feb 12, 2024

Primary completion

Oct 2027

Study completion Apr 2028

Sponsor

Lead sponsor
Frontier Medicines CorporationIndustry
Sponsor type
Industry
First posted
Feb 6, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to evaluate FMC-376 monotherapy and in combination with pembrolizumab in participants with advanced solid tumors with KRAS G12C mutations. This clinical trial will be conducted in 3 parts: Phase 1A (Dose Escalation), Phase 1B (Dose Expansion), and Phase 2 (Cohort Expansion). Multiple dose levels in participants with advanced solid tumors will be evaluated.

Conditions

  • Advanced Solid Tumors With KRAS G12C Mutations
  • Solid Tumor, Adult
  • Unresectable Solid Tumor
  • Metastatic Solid Tumor
  • Non Small Cell Lung Cancer
  • KRAS G12C

Interventions

  • FMC-376Drug

    Oral Daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ph 1a: Dose Limiting ToxicitiesTime frame: Up to 21 Days
  2. Ph 1a: Adverse Events (AEs)Time frame: Approximately 24 Months
  3. Ph 1b/Ph2: Overall Response Rate (ORR)Time frame: Approximately 24 Months

Locations

26 sites in 3 countries. Site status is shown where the registry gives one.

  • University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center

    La Jolla, California · Recruiting

  • University of California Irvine (UCI) - Chao Family Comprehensive Cancer Center

    Orange, California · Completed

  • University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center

    San Francisco, California · Recruiting

  • Florida Cancer Specialists and Research Institute

    Lake Mary, Florida · Completed

  • Northwest Cancer Centers

    Dyer, Indiana · Recruiting

  • The University of Kansas Cancer Center

    Fairway, Kansas · Recruiting

  • Dana-Farber Cancer Institute

    Boston, Massachusetts · Recruiting

  • Karmanos Cancer Institute

    Detroit, Michigan · Recruiting

  • University of Pennsylvania

    Philadelphia, Pennsylvania · Recruiting

  • The University of Texas MD Anderson Cancer Center

    Houston, Texas · Recruiting

  • Community Clinical Trials

    Kingwood, Texas · Completed

  • South Texas Accelerated Research Therapeutics, LLC

    San Antonio, Texas · Recruiting

  • UT Health San Antonio

    San Antonio, Texas · Recruiting

  • START Mountain Region

    West Valley City, Utah · Completed

  • Virginia Cancer Specialists

    Fairfax, Virginia · Recruiting

  • Macquarie University

    Macquarie Park, New South Wales, Australia · Recruiting

  • Tasman Health Care

    Southport, Queensland, Australia · Recruiting

  • Icon Cancer Centre Kurralta Park

    Kurralta Park, South Australia, Australia · Recruiting

  • GenesisCare North Adelaide

    North Adelaide, South Australia, Australia · Completed

  • Eastern Health - Box Hill Hospital

    Box Hill, Victoria, Australia · Completed

  • Linear Clinical Research Ltd

    Nedlands, Western Australia, Australia · Recruiting

  • Seoul National University Hospital

    Seoul, Jongno-gu, South Korea · Recruiting

  • Severance Hospital

    Seoul, Seodaemun-gu, South Korea · Recruiting

  • Korea University Anam Hospital

    Seoul, Seongbuk-gu, South Korea · Recruiting

  • Seoul National University Bundang Hospital

    Gyeonggi-do, Seongnam-si, South Korea · Recruiting

  • The Catholic University of Korea, St. Vincent's Hospital

    Gyeonggi-do, Suwon-si, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.